Medline ® Abstracts for References 62-66
of 'Contraceptive counseling and selection'
62
TI
Evaluation of smartphone oral contraceptive reminder applications.
AU
Gal N, Zite NB, Wallace LS
SO
Res Social Adm Pharm. 2015 Jul-Aug;11(4):584-7. Epub 2014 Dec 16.
BACKGROUND:
Oral contraceptives (OCs) are the most widely used contraceptive method among women of reproductive age in the United States (US). Routine download and use of health-related smartphone applications (apps) continues to increase.
OBJECTIVE:
The purpose of this study was to evaluate the utility of English-language, smartphone-platform OC reminder apps currently available for download in the US.
METHODS:
During June-July 2013, official Internet-based, mobile app platforms for the two major smartphone operating systems in the US-Android (Google Play Store) and iPhone (iTunes)-were searched. "Birth control," "the pill," and "contraception" were entered into the search-bar of each Smartphone store. Apps were assessed for the following: cost, health care professionals' involvement in app development, reminder mechanisms, and functionality.
RESULTS:
Of the 39 unique OC reminder apps meeting inclusion criteria, 7 (18%) did not operate as intended when downloaded. Most apps functioned without an Internet connection (97%) and included pop-up notifications (84%).
CONCLUSIONS:
Certain app features overcome common causes of missing an alarm, and hypothetically, may minimize likelihood of an OC user missing a daily pill. Health care providers should inform users of potential pitfalls and advise them that an OC reminder app should be not be used as a sole reminder method.
AD
The Ohio State University, College of Medicine, Columbus, OH 43201, USA.
PMID
63
TI
Impact of Reminder Systems in Clinical Settings to Improve Family Planning Outcomes: A Systematic Review.
AU
Zapata LB, Tregear SJ, Tiller M, Pazol K, Mautone-Smith N, Gavin LE
SO
Am J Prev Med. 2015 Aug;49(2 Suppl 1):S57-64.
CONTEXT:
This systematic review evaluated the evidence on the impact of family planning reminder systems-interventions intended to remind patients of behaviors to achieve reproductive health goals (e.g., daily text messages reminding oral contraceptive [OC]users to take a pill)-to provide information to guide national recommendations on quality family planning services.
EVIDENCE ACQUISITION:
Multiple databases including PubMed were searched during 2010-2011 for peer-reviewed articles published in English from January 1985 through February 2011 describing studies evaluating reminder systems to improve family planning outcomes. Studies were excluded if they focused primarily on HIV or sexually transmitted infection prevention, focused solely on men, or were conducted outside the U.S., Europe, Australia, or New Zealand.
EVIDENCE SYNTHESIS:
The initial search identified 16,129 articles, five of which met the inclusion criteria. Three studies examined the impact of OC reminder systems; two found a statistically significant positive impact on correct use. Two studies examined the impact of reminder systems among depot medroxyprogesterone acetate (DMPA) users; one found a statistically significant positive impact on correct use.
CONCLUSIONS:
Although mixed support was found for the effectiveness of reminder system interventions on correct use of OCs and DMPA, the highest-quality evidence yielded null findings. The evidence base would be strengthened by the development of additional studies, especially RCTs, which objectively measure outcomes, examine additional contraceptive methods, and have sufficient sample sizes to detect behavioral outcomes at least 12 months post-intervention.
AD
Division of Reproductive Health, CDC, Atlanta, Georgia. Electronic address: lzapata@cdc.gov.
PMID
64
TI
Text Messaging Support for Urban Adolescents and Young Adults Using Injectable Contraception: Outcomes of the DepoText Pilot Trial.
AU
Trent M, Thompson C, Tomaszewski K
SO
J Adolesc Health. 2015 Jul;57(1):100-6. Epub 2015 May 19.
PURPOSE:
To evaluate the feasibility, acceptability, and preliminary effectiveness of DepoText, a text messaging reminder system designed to improve moderately long-acting reversible contraception appointment attendance among young urban adolescent girls and young adult women using Depo-Provera.
METHODS:
Female patients aged 13-21 years willing to be randomized, using Depo-Provera, and owning a cell phone with text messaging were recruited from an urban academic practice in a community with high rates of unplanned pregnancy for this institutional review board-approved randomized controlled pilot trial. Participants completed a baseline Web-based survey and were followed for three injection cycles. Intervention participants received welcome, appointment, and healthy self-management messages using the Compliance for Life short messaging system platform over each injection cycle. Compliance for Life recorded outgoing and incoming communications, and patients were tracked for clinical behaviors. The log-transformed number of days between scheduled appointment and injection was analyzed using linear regression.
RESULTS:
Recruitment data show 95% eligibility and 91% enrollment rates with maximum enrollment completion in 3 months. Most were African-American and resided in low-income, single-parent, and mother-headed households. Most participants had cell phone plans that included unlimited text messaging and Internet access and completed all three Depo-Provera cycles. Intervention participants returned closer to their scheduled appointments than their control peers for the first visit (Β = -.75; 95% confidence interval, -1.4 to .06; p = .03) but not for the second and third visits.
CONCLUSIONS:
The DepoText intervention is acceptable, feasible, and shows short-term preliminary efficacy for improving clinic attendance for moderately long-acting reversible contraception appointments. Additional research exploring the cost and longitudinal prevention effectiveness is warranted.
AD
Section on Adolescent Medicine, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Population, Family, and Reproductive Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. Electronic address: mtrent2@jhmi.edu.
PMID
65
TI
Using daily text-message reminders to improve adherence with oral contraceptives: a randomized controlled trial.
AU
Hou MY, Hurwitz S, Kavanagh E, Fortin J, Goldberg AB
SO
Obstet Gynecol. 2010 Sep;116(3):633-40.
OBJECTIVE:
To estimate whether women receiving daily text-message reminders have increased oral contraceptive pill adherence compared with women not receiving reminders.
METHODS:
This randomized controlled trial estimated whether there was an effect of daily text-message reminders on oral contraceptive pill adherence of new oral contraceptive pill users. Pill-taking was tracked for 3 months by an electronic monitoring device with wireless data collection. During the study period, participants assigned the intervention received a daily reminder text message. Eighty-two women were assigned randomly to detect a 1.6+/-2.0 pill difference (90% power, 5% alpha, 15% dropout).
RESULTS:
Participants were 79% white, non-Hispanic, 99% high school graduates, and 99% nulliparous with a mean age of 22 years. Most reported condom use with past coital activity, and more than half reported prior emergency contraception use. The mean number of missed pills per cycle did not differ significantly between the groups: 4.9+/-3.0 for the text-message group and 4.6+/-3.5 for the control group (P=.60). The number of missed pills per cycle increased over the course of the study, but this pattern did not increase differentially between the groups. Adherence recorded by the electronic monitoring device indicated much poorer adherence than that recorded by patient diaries. Despite poor pill-taking, there were no pregnancies.
CONCLUSION:
Daily text-message reminders did not improve oral contraceptive pill adherence. Although the lack of benefit may be attributed to the frequent use of alternative reminder systems in the control group, the rate of missed pills when measured objectively was still very high in both groups.
CLINICAL TRIAL REGISTRATION:
Clinicaltrials.gov, www.clinicaltrials.gov, NCT00733707.
LEVEL OF EVIDENCE:
I.
AD
Boston University School of Medicine, Boston, Massachusetts, USA. Melody.hou@bmc.org
PMID
66
TI
Effect of daily text messages on oral contraceptive continuation: a randomized controlled trial.
AU
Castaño PM, Bynum JY, Andrés R, Lara M, Westhoff C
SO
Obstet Gynecol. 2012;119(1):14.
OBJECTIVE:
To estimate whether daily educational text messages affect oral contraceptive pill (OCP) continuation at 6 months.
METHODS:
We randomized young women electing OCPs at an urban family planning health center to either routine care or routine care plus 180 days of daily educational text messages. Investigators masked to treatment allocation randomized participants who were not masked to treatment. The primary outcome measure was self-reported OCP continuation through a telephone call at 6 months (contacts between 5 and 8 months).
RESULTS:
We enrolled 962 participants (480 intervention and 482 routine care) and obtained continuation data on 683 (346 and 337, respectively). At the follow-up, 64% of participants randomized to the intervention were still OCP users compared with 54% of the routine care group (P=.005). Continuation was highest in the intervention group if the interview took place while the intervention was ongoing (75% compared with 54%, P=.003); the effect of the intervention on continuation was less after the intervention ended (60% compared with 54%, P=.16). Participants receiving the intervention were more likely to continue oral contraception than control participants at 6 months (odds ratio 1.44, 95% confidence interval 1.03-2.00) in analyses adjusted for age, race or ethnicity, age at coitarche, pregnancy history, and OCP experience.
CONCLUSION:
The use of daily educational text messages improves OCP continuation at 6 months over routine care alone. Ten women would need to receive this simple intervention to improve continuation in one. This effect is strongest in the women whose follow-up took place while the text intervention was ongoing.
CLINICAL TRIAL REGISTRATION:
ClinicalTrials.gov, www.ClinicalTrials.gov, NCT00677703.
AD
Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, New York 10032, USA. pc2137@columbia.edu
PMID
